Skin Specialists, Pc

Clinical research site in Omaha, Nebraska · 2802 OAK VIEW DR, OMAHA, NE 68144-5604 · (402) 334-7546

As of July 2026, 7 paid clinical trials are recruiting at Skin Specialists, Pc in Omaha, Nebraska. Active studies at this site cover conditions such as Atopic Dermatitis, Alopecia Areata and Dermatitis Atopic. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Skin Specialists, Pc (7)

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for Atopic Dermatitis

66 locations incl. Birmingham

Sponsor: AbbVie

Sex: All·Age: 18 - 63

Code: NCT06389136·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for Alopecia Areata

39 locations incl. Chula Vista

Sponsor: AbbVie

Sex: All·Age: 12 - 63

Code: NCT06012240·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

for Dermatitis Atopic

43 locations incl. Birmingham

Sponsor: Sanofi

Sex: All·Age: 12+

Code: NCT06241118·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

for Atopic Dermatitis

26 locations incl. Little Rock

Sponsor: AbbVie

Sex: All·Age: 2 - 11

Code: NCT06461897·Phase 3·Recruiting·Listed Jun 2024

Apply to this trial

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for Alopecia Areata

54 locations incl. Birmingham

Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All·Age: 12 - 17

Code: NCT07133308·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for Non-segmental Vitiligo

21 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 99

Code: NCT07431177·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections

for Healthy Volunteer

21 locations incl. Birmingham

Sponsor: AbbVie

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07232004·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

More research sites in Omaha

University of Nebraska Medical Center (213 trials)
Nebraska Cancer Specialists (37 trials)
Nebraska Medicine-Village Pointe (36 trials)
Children's Hospital and Medical Center of Omaha (29 trials)
Alegent Health Bergan Mercy Medical Center (26 trials)
Nebraska Methodist Hospital (26 trials)
Alegent Health Immanuel Medical Center (23 trials)
Alegent Health Lakeside Hospital (23 trials)
Creighton University Medical Center (16 trials)
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC (16 trials)

Explore more

Paid clinical trials in Omaha, NE · Nebraska clinical trials